+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

Basilea Pharmaceutica

BPMUFOTCEM

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$47.00

00.00%

Last update: Jul 17, 2:00 PM

15 minutes delayed

Basilea Pharmaceutica (BPMUF) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Basilea Pharmaceutica (OTC:BPMUF) Stock

Basilea Pharmaceutica Stock (OTC: BPMUF)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, July 15, 2020

Basilea Reports Pfizer has Launched Antifungal Cresemba in Taiwan, Triggering Second Milestone Payment Related to Asia-Pacific
Charles Gross

Monday, June 22, 2020

Basilea Receives CHF 5M Milestone Payment from Pfizer Related to Marketing Authorization of Antifungal Cresemba in Russia
Charles Gross

Wednesday, January 10, 2018

Basilea Announces Completion of License Agreement Extension With Pfizer for Antifungal Cresemba for China and Asia Pacific
Benzinga

Friday, December 01, 2017

Pfizer, Basilea to Develop and Commercialize CRESEMBA in China and Asia Pacific Region
Benzinga

Tuesday, September 12, 2017

Basilea Announces Distribution Agreement with Cardiome to Commercialize Zevtera/Mabelio in Europe, Israel
Benzinga

Thursday, July 20, 2017

Pfizer Completes License Agreement for Exclusive Commercialization Rights in Europe for CRESEMBA ti Treat Potentially Life-Threatening Fungal Infections Among Immunocompromised Patients
Benzinga

Monday, October 12, 2015

Basilea Announces Health Canada Approves ZEVTERA to Treat Bacterial Lung Infections
Benzinga

Monday, December 22, 2014

Swiss Regulatory Authority Approves Basilea's Antibiotic Zevtera for Teatment of Pneumonia
Benzinga

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved